Cargando…

Mechanisms and Biomarkers of Apoptosis in Liver Disease and Fibrosis

Liver fibrosis and cirrhosis are a major cause of morbidity and mortality worldwide. Development of the fibrotic scar is an outcome of chronic liver diseases of varying aetiologies including alcoholic liver disease (ALD) nonalcoholic liver disease (NAFLD) including non-alcoholic steatohepatitis (NAS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chakraborty, Jayashree Bagchi, Oakley, Fiona, Walsh, Meagan J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3332069/ https://www.ncbi.nlm.nih.gov/pubmed/22567408 http://dx.doi.org/10.1155/2012/648915

Ejemplares similares

Serotonin paracrine signaling in tissue fibrosis()()
por: Mann, Derek A., et al.
Publicado: (2013)

A TLR2/S100A9/CXCL-2 signaling network is necessary for neutrophil recruitment in acute and chronic liver injury in the mouse
por: Moles, Anna, et al.
Publicado: (2014)

Noninvasive imaging biomarkers for liver fibrosis in nonalcoholic fatty liver disease: current and future
por: Yu, Jung Hwan, et al.
Publicado: (2023)

Mitochondrial Mechanisms of Apoptosis and Necroptosis in Liver Diseases
por: Chu, Qingfei, et al.
Publicado: (2021)

Clinical importance of laboratory biomarkers in liver fibrosis
por: Aleknavičiūtė-Valienė, Goda, et al.
Publicado: (2022)

Serum Biomarkers of Liver Fibrosis Staging in the Era of the Concept “Compensated Advanced Chronic Liver Disease”
por: Fujita, Koji, et al.
Publicado: (2021)

Hyaluronic acid as a biomarker of fibrosis in chronic liver diseases of different etiologies
por: ORASAN, OLGA HILDA, et al.
Publicado: (2016)

Liver fibrosis: a compilation on the biomarkers status and their significance during disease progression
por: Nallagangula, Krishna Sumanth, et al.
Publicado: (2017)

The roles and mechanisms of hypoxia in liver fibrosis
por: Cai, Jingyao, et al.
Publicado: (2021)

Liver Fibrosis and Protection Mechanisms Action of Medicinal Plants Targeting Apoptosis of Hepatocytes and Hepatic Stellate Cells
por: Duval, Florent, et al.
Publicado: (2014)

Role of Hepatocyte Senescence in the Activation of Hepatic Stellate Cells and Liver Fibrosis Progression
por: Wijayasiri, Pramudi, et al.
Publicado: (2022)

Serum Markers of Hepatocyte Death and Apoptosis Are Non Invasive Biomarkers of Severe Fibrosis in Patients with Alcoholic Liver Disease
por: Lavallard, Vanessa Jeannette, et al.
Publicado: (2011)

The Roles and Mechanisms of lncRNAs in Liver Fibrosis
por: He, Zhi, et al.
Publicado: (2020)

Noninvasive serum biomarkers for liver fibrosis in NAFLD: current and future
por: Reinson, Tina, et al.
Publicado: (2023)

Gut Microbiota and Liver Fibrosis: One Potential Biomarker for Predicting Liver Fibrosis
por: Li, Zhiming, et al.
Publicado: (2020)

Molecular Mechanisms of Liver Fibrosis in HIV/HCV Coinfection
por: Mastroianni, Claudio M., et al.
Publicado: (2014)

Mechanisms Underlying Cell Therapy in Liver Fibrosis: An Overview
por: Pinheiro, Daphne, et al.
Publicado: (2019)

Cellular and Molecular Mechanisms Underlying Liver Fibrosis Regression
por: Caligiuri, Alessandra, et al.
Publicado: (2021)

Overview of CircRNAs Roles and Mechanisms in Liver Fibrosis
por: Wang, Gaiping, et al.
Publicado: (2023)

Sinusoidal and pericellular fibrosis in adult post-transplant liver biopsies: association with hepatic stellate cell activation and patient outcome
por: Abou-Beih, Sameh, et al.
Publicado: (2019)

Liver disease in cystic fibrosis
por: Kobelska-Dubiel, Natalia, et al.
Publicado: (2014)

Non-invasive biomarkers of liver fibrosis in non-alcoholic fatty liver disease
por: Basheer, Maamon, et al.
Publicado: (2023)

Candidate Biomarkers of Liver Fibrosis: A Concise, Pathophysiology-oriented Review
por: Bellan, Mattia, et al.
Publicado: (2018)

Gas6/TAM Signaling Components as Novel Biomarkers of Liver Fibrosis
por: Smirne, Carlo, et al.
Publicado: (2019)

Obesity Modifies the Performance of Fibrosis Biomarkers in Nonalcoholic Fatty Liver Disease
por: Qadri, Sami, et al.
Publicado: (2021)

Liver Disease in Cystic Fibrosis: an Update
por: Parisi, Giuseppe Fabio, et al.
Publicado: (2013)

Non-alcoholic Fatty Liver Disease and Liver Fibrosis during Aging
por: Li, Yuan, et al.
Publicado: (2022)

Molecular Mechanism and Treatment of Viral Hepatitis-Related Liver Fibrosis
por: Su, Tung-Hung, et al.
Publicado: (2014)

Molecular Mechanisms That Link Oxidative Stress, Inflammation, and Fibrosis in the Liver
por: Ramos-Tovar, Erika, et al.
Publicado: (2020)

The Molecular Mechanisms of Liver Fibrosis and Its Potential Therapy in Application
por: Zhang, Danyan, et al.
Publicado: (2022)

Liver Fibrosis Resolution: From Molecular Mechanisms to Therapeutic Opportunities
por: Pei, Qiying, et al.
Publicado: (2023)

In Vivo and In Vitro Models to Study Liver Fibrosis: Mechanisms and Limitations
por: Lee, Young-Sun, et al.
Publicado: (2023)

Microvascular Thrombosis and Liver Fibrosis Progression: Mechanisms and Clinical Applications
por: Airola, Carlo, et al.
Publicado: (2023)

Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
por: Ramai, Daryl, et al.
Publicado: (2021)

Oral Submucous Fibrosis: A Review on Biomarkers, Pathogenic Mechanisms, and Treatments
por: Shen, Yen-Wen, et al.
Publicado: (2020)

Gas6 in chronic liver disease—a novel blood-based biomarker for liver fibrosis
por: Staufer, Katharina, et al.
Publicado: (2023)

Liver Fibrosis—From Mechanisms of Injury to Modulation of Disease
por: Liedtke, Christian, et al.
Publicado: (2022)

Cellular Mechanisms of Liver Fibrosis
por: Acharya, Pragyan, et al.
Publicado: (2021)

Mechanisms of Accelerated Liver Fibrosis Progression during HIV Infection
por: Debes, Jose D., et al.
Publicado: (2016)

Damaged-DNA Binding Protein-2 Drives Apoptosis Following DNA Damage
por: Bagchi, Srilata, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_c5istekkuaf7btpr4ngoebusqb